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Patient lists are project-speciﬁc sets of patients that can be queried in integrated data repositories (IDR’s).
By allowing a set of patients to be an addition to the qualifying conditions of a query, returned results will
refer to, and only to, that set of patients. We report a variety of use cases for such lists, including: restrict-
ing retrospective chart review to a deﬁned set of patients; following a set of patients for practice man-
agement purposes; distributing ‘‘honest-brokered’’ (deidentiﬁed) data; adding phenotypes to
biosamples; and enhancing the content of study or registry data. Among the capabilities needed to imple-
ment patient lists in an IDR are: capture of patient identiﬁers from a query and feedback of these into the
IDR; the existence of a permanent internal identiﬁer in the IDR that is mappable to external identiﬁers;
the ability to add queryable attributes to the IDR; the ability to merge data from multiple queries; and
suitable control over user access and de-identiﬁcation of results. We implemented patient lists in a cus-
tom IDR of our own design. We reviewed capabilities of other published IDRs for focusing on sets of
patients. The widely used i2b2 IDR platform has various ways to address patient sets, and it could be
modiﬁed to add the low-overhead version of patient lists that we describe.
 2014 Elsevier Inc. All rights reserved.1. Introduction
We are well into the era of ‘‘secondary use’’ of health data [1], of
which an important part is reusing clinical data for both publish-
able research and quality improvement [2]. A 2010 survey [3] de-
ﬁned ‘‘integrated data repository’’ (IDR) as a data warehouse
integrating various sources of clinical data to support queries for
a range of research-like functions. IDRs for research are usually de-
signed to allow ‘‘attribute-centric’’ queries [4]: that is, queries for
the set of patients who meet some criteria based on values of clin-
ical observations or characteristics (also called ‘‘attributes’’ in the
common Entity–Attribute–Value (EAV) model [5,6]). An example
might be, ‘‘Give me all the patients who have more than one
admission and are on inhaled corticosteroids.’’ Dinu and Nadkarni
[7] said that clinical care systems are, in contrast, optimized to re-
trieve many or all attribute values for a particular patient. An
example would be displaying the entire electronic chart for a se-
lected patient. They also noted an occasional need to do both at
once – to retrieve a speciﬁed set of attributes for a speciﬁed set
of patients. They called this ‘‘bulk data extraction,’’ a name sugges-
tive of exceptions and custom programming. We will call this a pa-tient list query. An example might be ‘‘For my pre-deﬁned set of
patients, ﬁlter them by those who have had a chest CT and return
their current meds and pulmonary function test results.’’ IDRs de-
signed to query for speciﬁed sets of patients in this way seem to be
rare or limited in the capability. In our own IDR [6] we have discov-
ered a variety of uses for such a function. Primarily these involve
query for detailed, patient-level data rather than aggregations.
We shall illustrate the value of patient lists with a number of use
cases, describe methods for addressing related technical and gov-
ernance issues, and then discuss the concept with regard to i2b2.1.1. IDR query capabilities
IDRs are complex systems that have to solve a variety of prob-
lems, including: identity management, semantic and syntactic
comparability of data from different sources, protection of conﬁ-
dentiality, convenient and ﬂexible query, and the performance
and usability issues arising from the sheer volumes and varieties
of medical data [6,8]. The ability of such systems to support pa-
tient-list query varies.
One approach to an IDR is to simplify governance by irreversibly
de-identifying all data, as in Vanderbilt’s BioVU DNA Biobank [9].
This would necessarily preclude query about a known (i.e., identi-
ﬁed) set of patients.
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trial-scale data modeling of healthcare concepts to a relationally
normalized database. From this they extract a dimensional model
[11] to support ad hoc query by using standard commercial tools.
Dimensional models are used for queries that aggregate data
across selected dimensions, such as time or location, that cut
across all records. Other attribute values pertaining to individual
patients, such as speciﬁc drugs, conditions or procedures, would
not be available for selecting data in a dimensional query.
The National Institutes of Health has an intramural IDR called
BTRIS [12] to hold data from numerous research studies. BTRIS
supports query by providing an interface with templates in which
users can select values of clinical and demographic attributes for
ﬁltering returned data. Because protocols are a high-level concept
in this system, an investigator can focus a query on the subjects in
their own study. They also offer ‘‘list reports’’ to create lists of pa-
tients ‘‘that can be used as ﬁlters for other reports’’. This seems like
a form of query by patient list.
The recent IDR survey [3] noted, by comparison to a previous
survey, trends for substantial and increasing use of ﬂexible, ad
hoc user query interfaces (as opposed to custom programming
for data extraction) and automatically de-identiﬁed data (during
either data loading or output). One such system is Stanford’s
STRIDE IDR [13]. It supports a clinical data warehouse, individual
research project data management, and a biorepository. The
underlying data model is EAV, accessed by two graphical user
query interfaces with granular access control and with the ability
to release data that has varying levels of de-identiﬁcation. All are
features that it shares with the widely used i2b2 platform [14].
STRIDE allows users to discover and save patient cohorts, which
sounds like the internally-deﬁned patient lists that we describe la-
ter. i2b2’s suitability for patient list query is discussed in detail
later.
This paper will illustrate patient list uses and concepts at Na-
tional Jewish Health in a custom-designed IDR [6], known to us
simply as the RDB (Research Database). The RDB uses a unique data
model called a ‘‘dimensional bus’’, implemented on a SQL Server
2005 database platform. It has a custom query user interface, pro-
grammed using the ColdFusion language, that compiles T-SQL que-
ries at run time. This interface gives highly expressive, ad hoc and
simultaneous query of any attribute of clinical, research and bior-
epository data. Data in the RDB come from an Allscripts EHR (elec-
tronic health record), a Freezerworks sample management system,
and our custom-programmed clinical data management system,
Study Design by Metadata (SDM).
All researchers are allowed to query the RDB for record frequen-
cies, obscured to protect privacy. Query for individual-level data is
controlled by issuing to individual research projects customized
‘‘Access Tickets.’’ The Tickets implement the institutional review
board’s (IRB) permissions specifying access to data sources, level
of de-identiﬁcation, and even patients’s consents for studies of a
certain type. The RDB can act as an automated honest broker
[15], by maintaining a link between a random internal identiﬁer,
called the ASID (Anonymous Subject IDentiﬁer) and direct identiﬁ-
ers such as patient name. All queries expose the ASID automati-
cally, but a study being allowed access to direct identiﬁers will
obtain those through a separate action by our database curator.2. Background
While the patient list capabilities of the RDB evolved incremen-
tally, with use cases and requirements in a feedback loop, we shall
present all our use cases (Table 1) ﬁrst as ‘‘motivation’’ for the
requirements.2.1. List from IDR query
(Table 1 case 1). Most of our lists are generated from internal
queries of our IDR. The initial query is usually one authorized by
the IRB for cohort discovery. In some cases the curator adds per-
sonal identiﬁers to that query to support subject recruitment. In
other cases the cohort is being used in retrospective research,
and so its composition is frozen because the IRB has restricted
the protocol to data existing at the time of protocol approval. In
either the prospective or retrospective model, a patient list allows
the researcher to learn more about the population: prospectively,
as new EHR data are acquired, or retrospectively, when different
types of observations are needed. Our IRB treats this as a safer form
of ‘‘chart review’’. Compared to unrestricted review of the medical
record, the IRB prefers queries by patient list in our IDR because: it
restricts the scope of review, it can de-identify the data, and it
leaves a detailed audit trail of accesses.
2.2. Add to existing study database
(Table 1 case 2). The patient list can be used to help with a very
common problem: acquiring data on regular clinical care for an
existing study sample [16]. We do this by constructing a list based
on the study’s identiﬁed patients. The study then uses the list to
query the repository’s EHR data for those patients, and links the
query results back into the study database, using one of the mech-
anisms described in Section 3.5.
2.3. EHR-derived List
(Table 1 case 3). Users needing data to support population
health management might supply us a list of clinical patients that
also included, for example, data on the stage of a patient’s treat-
ment or disease, or the projected date of some follow-up visit.
These variables can be used in IDR queries returning information
on selected subsets of the list. An important source of patient lists
could be the lists that are part of the CMS (Centers for Medicare
and Medicaid Services) EHR Meaningful Use objectives [17]. The
objective asks eligible professionals to ‘‘Generate lists of patients
by speciﬁc conditions to use for quality improvement, reduction
of disparities, research, or outreach’’ [18]. Encouraging the export
of such lists from EHRs to a linked IDR would open new possibili-
ties for making their use more ‘‘meaningful’’. We currently have
one EHR-generated patient list, part of an Alpha-1 antitrypsin deﬁ-
ciency registry, that we update with each data load. The clinician
uses the list to monitor if the follow-up visits have occurred and
to check on population level lab results.
2.4. Honest brokering
(Table 1 case 4). Our IDR [6], like others [14] can act as an auto-
mated ‘‘honest broker’’ [15] because it can de-identify data and
maintain the coded key (the ASID) to it. Our IDR can, by using a pa-
tient list, also be helpful when our Honest Broker Service de-iden-
tiﬁes data from sources outside the IDR. Brokers from our Service
can create a patient list containing data that they have de-identi-
ﬁed. By giving the researcher an Access Ticket that allows query
of that list, we ‘‘deliver’’ the brokered data, but also can allow them
to make queries for additional, de-identiﬁed, IDR data on their
patients.
2.5. Biobanking
(Table 1 case 5). Researchers can use our IDR to search for insti-
tutional biobank specimens whose donors have speciﬁc clinical
attributes. We have created patient lists derived from such
Table 1
Use cases for patient lists in an IDR. These are cases we have implemented on our IDR.
List use case Objectives List origin
1. List from IDR query Internal query deﬁning a study cohort. Researchers can return for additional data without cluttering results with
original sample-deﬁning values
Internal query
2. Add to existing study
database
Get EHR data for consented study participants External
(study)
3. EHR-derived list Get population data on a clinically relevant group of patients for practice management or ‘‘Meaningful Use’’ External (EHR)
4. Honest brokering Allows dissemination of brokered de-identiﬁed data and connection with IDR data External
5. Biobanking Add phenotypes to biosamples Internal or
external
6. Access to study/registry
data
Allows queries of study and EHR data together Internal query
7. Promoting collaboration Share aggregate information on a population to promote collaborator interest Internal or
external
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donors for stratiﬁed randomization or other research purposes. For
example, one study identiﬁed biosamples based on whether the
patient had certain allergy testing done, but needed to be blinded
to test status until all their samples were assayed as part of the
study protocol. Once they had their results, we created a patient
list so they could query for clinical information such as diagnosis,
skin test results, and IgE levels for each sample/subject.
Honest brokering is used for another biobank, our Live Cell Core.
The Core is chartered to operate as non-human subjects research,
because honest brokers de-identify the cell specimens right after
collection, and donors are not consented for particular studies. This
severely limits the phenotypic information available. However, a
researcher can apply to the Honest Broker Service to obtain more
detailed phenotypes. The Service can implement this by making a
patient list of the donors and then making IDR queries from the list.2.6. Access to study/registry data
(Table 1 case 6). There are a few large or long-term studies that
have found it useful to load their entire study databases into our
IDR. If the study data are periodically updated in the IDR, this
arrangement has some similarity to a ‘‘registry’’ [19] (see also the
discussion of i2b2 later). Having a study database in the IDR has
two advantages. First, the study can use the IDR’s powerful query
capabilities to explore their own data. Second, an Access Ticket
can be issued to allow a new collaborator with the study to exam-
ine study data or to link it to other data in the IDR that was not part
of the original study.
In data from a complex study or registry there might not be any
variable that can be used in a condition to select all subjects in the
study. To meet this need we add a patient list of all the subjects in a
study. Other attributes in a list, which can hold patient character-
istics or study status (Sections 3.1 and 3.5 explain how list attri-
butes are added), can be used synergistically with study data to
provide easily deﬁned subsets of subjects for registry, study or col-
laboration purposes. We use three overlapping patient lists to track
processes in our automated cancer registry (which is partially
imbedded in our IDR) for state reporting.2.7. Promoting collaboration
(Table 1 case 7). Our system allows query for privacy-safe fre-
quencies (patient counts) to any local researcher, without needing
protocol approval. We decided to allow our patient lists to appear
in the catalog of data items allowed in frequency queries. We rea-
soned that it might encourage research collaboration for research-
ers to be aware of the existence and sample size (revealable by a
frequency query) of each other’s lists. One researcher with a large
collection of bio-samples created a patient list so that he could di-rect colleagues to the IDR when they asked about available samples
and about overlap with their own study criteria.
3. Material and methods
We developed the ability to query data from our IDR where the
query is restricted to a particular subset, called a patient list, of the
patients in the IDR. In Table 2we deﬁne the level of need for various
functional capabilities when using patient lists from two types of
sources. In the ﬁrst instance the patient list gets deﬁned internally
by a query of the IDR. In the second instance the list is supplied
externally from a source outside the IDR. These requirements guided
our implementation. We shall note general implementation issues,
but detailed guidance for other IDRs could only be based on deeper
knowledge of those systems than we have. We note below when a
requirement has speciﬁc relevance to particular use cases. All but
one of the use cases (Table 1, case 7) assume that IDR query can re-
turn individual-level data, not just frequencies.
3.1. Feedback from internal query
(Table 2 row 1). After their initial queries of our IDR we found
that users often wanted to come back for more data on the same
sample of patients. Our users could save the logic of their discovery
query and modify it to return more types of observations. How-
ever, as our IDR always gained more data and more patients every
month, the same query qualifying conditions executed later would
usually return more patients than were originally discovered, thus
creating a moving target for the researcher.
In the case of retrospective research, IRB approval might have
been given to study the discovered, point-in-time, sample only.
In the case of prospective research the researcher might want to
follow only the initially discovered sample over time, extracting
new observations, but not new patients, from the IDR. In either
case the use of stored queries based on attribute values is
problematic.
To solve this problemwe added a newworkﬂow. After our users
save an attribute-based query, they can request that the set of pa-
tients that it found be used to create a patient list. The list consists
of a set of tuples of the form, {ASID, ListX.member}, where the
attribute, ListX.member, has a value meaning ‘‘is a member of list
X’’. With the list added as queryable data to the IDR, queries can in-
clude ListX.member in a query condition to restrict any returned
data to refer to only list members. An example is given in Fig. 1.
This requirement enables use cases 1, 5 and 6.
3.2. Permanent Identiﬁer
(Table 2 row 2). IDRs logically need to have an internal, perma-
nent identiﬁer to designate distinct individual patients and to
merge information on individuals from various sources. Some of
Table 2
Needs for speciﬁed capabilities in implementing patient lists. The set of patients in a list can originate from an internal IDR query or from an external source such as a study or
clinical database.
Functional capability Origin of list
Internal query External source
1. Feedback from internal query: Feed patient IDs from a query result back to the IDR Needed Not needed
2. Permanent identiﬁer: Exposability of a permanent ID in the IDR Needed Needed
3. Adding attributes to IDR: Allow adding queryable attributes to IDR Needed Needed
4. Convert external ID: Ability to convert external ID to IDR’s standard ID Not needed Needed
5. Merge multiple queries: Merge multiple accessions of a list on common identiﬁers Needed Needed
6. Modifying list membership: Allow modiﬁcation of list membership over time Less likely More likely
7. Policies on de-identiﬁcation: Implement policies on levels of de-identiﬁcation on data returned from list-based query Needed Needed
8. Restricted use: Ability to restrict use of a list to authorized persons Needed Needed
9. Avoid inadvertent exposure: Use of a list in a query must not inadvertently expose unauthorized data Needed Needed
Fig. 1. Data ﬂow examples for patient lists in an integrated data repository. There are two types of lists, one type (list_A) generated externally to the IDR, and the other type
(list_B) generated from a query to the IDR itself. Hexagons number a sequence of events for each type of list. B.1 is a list-deﬁning internal query, and B.2 is the creation of a list
from that query. The A sequence shows creation of a list (A.1 and A.2) from data external to the IDR, followed by a query about the list (A.3), and the return of results (A.4)
from that query. The identities in the external list are coded by reference to data in the Master Patient Index. Coded ID’s and list membership variables are fed into the IDR,
and list data (e.g., the list_A.member Boolean) can then be used by a study in queries to restrict returned data to only list members.
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or some relatively enduring surrogate identiﬁer that is mapped 1:1
to the permanent one, can be revealed to users, thus allowing lon-
gitudinal followup information to be acquired later. We believe
this to be a requirement for any realistic application of patient lists.
The IDR at National Jewish Health can reveal such an identiﬁer [6],
a randomly chosen number that we call the ASID (Anonymous Sub-
ject IDentiﬁer). The i2b2 system can expose such an identiﬁer [14],
but for governance reasons some other IDRs [9,20] do not.
3.3. Adding attributes to IDR
(Table 2 row3).We implemented our patient lists by creating new
attributes (see explanations related to ‘‘tuples’’ in Sections 3.1 and
3.5) to query in our IDR. This is easiest in repositories, such as ours
[6] or i2b2 [14], that addattributesusingamodiﬁable datadictionary.
3.4. Convert external ID
(Table 2 row 4). If a list of patients comes from a source external
to the IDR, they will have to be mapped to the internal permanent
identiﬁer, thus allowing them to be used as data in the IDR. By pol-icy our internal identiﬁer, even though it is a part of the results of
any query, is never to be used for re-identiﬁcation of a patient.
Therefore, an external source can only designate a list patient by
supplying direct identiﬁers, such as name or medical record num-
ber. Mapping of a direct identiﬁer to the internal ID can only be
done if the IDR maintains such a link. Some IDRs, like ours, main-
tain a link from real identities to internal identities [6,14] and some
either do not [20] or may forbid its use by policy [9]. This require-
ment enables use cases 2, 3, 4 and 5.
We allow users to request creation of a patient list using any di-
rect identiﬁer that is tracked in our master patient index, including
full name, medical record number, and study identiﬁer (for pa-
tients who also have study data in our IDR).3.5. Merge multiple queries
(Table 2 row 5). Use of a patient list always results in adding to
existing information that is held by the researcher on those pa-
tients. If the list is created by an internal query, subsequent queries
on the list are meant to add to the data gained by the initial query.
Users can merge these data using the exposed internal identiﬁer
(in our case, the ASID).
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query results need to be merged to the data in the external source.
One solution is to add to the list tuples a surrogate identiﬁer such
as a study id. So a tuple would look something like {ASID,
ListY.member, studyID}. Queries of the list can therefore return
the studyID for use in merging. This means that access to the stud-
yID attribute must only be allowed for the researchers originating
the list, who by deﬁnition already know the patients’ real identi-
ties. Another solution is for the IDR curator to give the list user a
table that crosswalks the ASID (the ASID is automatically included
in query results) and whatever direct identiﬁer was originally used
to create the list. In either solution, note that the list user eventu-
ally sees an association of the ASID with the direct identiﬁer. This is
sometimes allowed because researchers agree in their protocol
that protected health information, which includes knowledge of
this association, can only be used within their project. In other
cases the IDR curator does the queries for the researcher, delivering
query results that expose only the direct identiﬁer, already known
to the researcher, instead of the ASID. These linking issues are most
relevant to use case 2.
3.6. Modifying list membership
(Table 2 row 6). Some projects have requested that the mem-
bership of a list be modiﬁed after its initial creation. As long as this
does not conﬂict with their IRB-approved protocol, we will do this
for them. We ﬁnd that externally-sourced lists are more likely to
have modiﬁcations requested, so this requirement relates most
to use cases 2, 3 and 6.
3.7. Policies on de-identiﬁcation
(Table 2 row 7). A repository must be able to implement any le-
vel of de-identiﬁcation [21] of data that is required by local gover-
nance (e.g., IRB or Privacy Ofﬁce) to protect results of queries that
use a particular patient list. In doing automated de-identiﬁcation of
queried data, an IDR is, in essence, acting as an honest broker [15].
In our IDR [6] we can issue a research project an Access Ticket that
prescribes which data they can query (e.g., a particular patient list
and medical record data) and the level of de-identiﬁcation (e.g.,
protected health information, HIPAA (Health Insurance Portability
and Accountability Act) limited data set, or HIPAA de-identiﬁed).
De-identiﬁcation happens more often in use cases 4 and 5.
3.8. Restricted use
(Table 2 row 8). Patient lists are intended to be used only by
particular authorized projects when querying for patient-level
data. Thus there needs to be a way to restrict a list’s use to the
researchers authorized to query for the project. We do this by
assigning a project’s Access Ticket to individual logins, and require
that a person logging in should select only one Access Ticket from
among any Tickets they have.
3.9. Avoid inadvertent exposure
(Table 2 row 9). Queries using a list should only return data
about the patients on the list. This requires close attention to the
workings of a query processor. In our case when an Access Ticket
authorizes use of a patient list, software will force any query to in-
clude an attribute from the list in the query conditions. With such a
Ticket, software also prohibits the use of a non-patient list attri-
bute as a logical OR condition in the query. For example, a query
for list membership OR patients with no mental health diagnosis
would be prohibited. Both restrictions prevent exposure of data
on non-list patients.3.10. Data ﬂow
Fig. 1 shows examples of the sequence of ﬂow of data in creat-
ing a list from an external source (steps A.1 and A.2) and from an
internal query (steps B.1 and B.2). Steps A.3 and A.4 show a study
using an external list to query the IDR for new information about
the list patients. Note that the external list uses a reference to a
Master Patient Index to translate medical record numbers into
the internal patient ID code. No such translation is needed for
the internally-sourced list, which already contains the internal
code.3.11. Applicability to a common IDR platform
Our lists are used in a custom IDR [6]. We analyzed the use of
the popular i2b2 platform [14] at Children’s Hospital Colorado
(CHCO) to learn the extent to which similar functionality might ex-
ist, or be created, in that widely-used platform. We found that not
all features of what we are calling a patient list exist in i2b2, but
there is no barrier to implementing such a feature. i2b2 queries
are built around a set of concepts, called its ontology, that are
user-determined at a local installation. An i2b2 instance may refer-
ence an ontology combining standard terminologies like ICD-9-CM
or LOINC with a locally developed set of terms. The local terminol-
ogy might reference local laboratory test codes, or observations
particular to a study. Therefore concepts deﬁning data in multiple
patient lists, which might contain both standard and local terms
unique to a patient list, could be added readily.
An i2b2 query returns a de-identiﬁed set of patients and the clin-
ical observations requested in the query. The logic of a query in i2b2
can be saved with a date range in its qualifying conditions, e.g., ‘All
patientswith encounters in 2012 having aDx of bronchiolitis and a PICU
visit’. Repeating the query laterwhen the database has beenupdated
should ﬁnd the same set of patients as before, exceptwhere the data
loading process has retroactively dropped or added qualifying pa-
tients due to identity adjustments. Once a query has been ‘‘frozen’’
by date, one can re-run the query, adding other conditions that are
not subject to the date range and thus get the same set of patients
with additional observations fromtheunderlyingdatabase.Our cus-
tom query engine at NJH [6] can be used in the same way.
There is no built-in method in i2b2 to deﬁne a patient list, de-
ﬁned as an independent set of queryable identities, without using
a frozen query as described above. However, there is no obvious
reason why such a method could not be developed, since i2b2 is
fully extensible in both query tool and data model.
Working solely with the ‘‘out-of-the-box’’ i2b2 implementation,
technical staff at CHCOmay create sub-populations by loading spe-
ciﬁc sets of patients or speciﬁc observations into an instance of
i2b2 called a ‘‘project’’. The methods available include:
1. Building an entirely separate instance of i2b2 for the data from
a study with its own ontology, or mapped to an existing i2b2
ontology.
2. Extracting a ‘‘data mart’’ that contains only the data of interest
for a study. This has a similar effect as #1, but may be easier.
3. Loading the data of a study into i2b2 and describing it within its
own branch of the ontology. At CHCO the production i2b2
instance has a terminology branch called ‘‘Registries’’ whose
immediate sub-trees each identify the data from a separate reg-
istry. Terms in the sub-trees may be built to reﬂect the observa-
tions recorded solely for a particular registry. Registry terms
may be supplemented with other terms in the non-registry por-
tion of the terminology tree, leveraging single-source-of-truth
data like demographics from the larger i2b2 instance.
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To date, we have created 30 patient lists covering the various
use cases in Table 1. One limitation to the applicability of a patient
list occurs when the source data for the list does not facilitate
matching to the identity directory of the IDR. Our Clinical Research
Unit had a database of patients interested in being research sub-
jects. We suggested that it would be valuable to query on a list
of those candidates in order to discover more qualifying informa-
tion about them in the IDR. However, the quality of identifying
information in the candidate database was too poor to make en-
ough conﬁdent matches, and the project was shelved pending
improvements in the candidate database.
Another limitation is that the purpose of a patient list must ﬁt
within the approved mission of the IDR itself. If the IDR, like some,
is not intended for use in direct patient care, then governance must
not allow patient lists with that purpose, although population
health/practice management purposes might be acceptable.
In our implementation, data on a patient list must be updated
by IDR staff, and adding more types of observations to the list re-
quires rebuilding the list with both new and old data included.
We have prototyped a way, which we call ‘‘Active Observations
Projects’’, for a project to design and load multiple patient lists
on its own and then manually update their data at any time. The
facility, taken with the query capabilities of the IDR, could provide
functionality similar to many patient registries, while also having
access to the much broader and deeper data of the IDR. Technical
challenges for this functionality involve coordinating real-time
data changes with the periodic loading cycle, and runtime match-
ing of new records to the correct ASID based on user-entered iden-
tiﬁers. Data used in queries should display or conceal real
identiﬁers, depending upon the application. This will complicate
the programming and governance related to ‘‘who is allowed to
see what identiﬁers and when.’’
5. Conclusions
Research enterprises have no doubt resorted to a variety of pro-
gramming solutions to accomplish the tasks that patient lists
helped us solve. The patient list concept works – almost automati-
cally – with an increasingly commonmodel [3]: research IDRs with
graphical query interfaces for attribute-centered queries and auto-
mated data de-identiﬁcation. The enabling concept of the patient
list is simple: that a pre-deﬁned set of patient identities can be
thought of as just another source of data in an IDR. Further, patient
lists are straightforward data structures which should not be bur-
densome to load into an IDR. Based on our experience, patient lists
can addmuch value to an IDR.We think that the patient list concept
can be adapted to different IDRs. The concept might even be appli-
cable to federated query systems [22,23] – if these have some kind
of overall identity management, so that a list of patient identities
can be transformed into whatever the federation uses.
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